市場調査レポート

商品コード

1701043

ゲノミクスの市場規模、シェア、成長分析：提供別、製品タイプ別、技術別、サービスタイプ別、用途別、研究タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Genomics Market Size, Share, and Growth Analysis, By Offering, By Product Type, By Technology, By Service Type, By Application, By Study Type, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月01日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ゲノミクス市場規模は、2023年に371億米ドルと評価され、2024年の416億6,000万米ドルから2032年には1,053億9,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは12.3％で成長する見通しです。

ゲノミクス分野は、DNAの構造、機能、マッピングの理解における進歩に牽引され、著しい変貌を遂げています。世界のがん罹患率の上昇に伴い、政府からの支援も増加し、革新的なゲノミクスプロジェクトに資金が供給されるようになっています。この急増は個別化医療の出現を可能にし、臨床腫瘍学や希少遺伝性疾患における治療戦略に革命をもたらしています。同時に、学術界は遺伝学と認知障害の相関関係を掘り下げ、ゲノミクスの応用をさらに拡大しています。がん研究への注目の高まりは、迅速な臨床診断への需要と相まって、政府機関やバイオ製薬会社からの旺盛な投資と相まって、ゲノミクス市場を急速な収益成長へと押し上げています。この多面的な進化は、ゲノミクスがヘルスケアとメディカルサイエンスに与える大きな影響を反映しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022～2024年）

主要企業プロファイル

Illumina, Inc.（US）
Thermo Fisher Scientific（US）
Qiagen N.V.（Netherlands）
BGI Group（China）
F. Hoffmann-La Roche AG（Switzerland）
Danaher Corporation（US）
Pacific Biosciences of California, Inc.（US）
Oxford Nanopore Technologies, Ltd.（United Kingdom）
Eurofins Scientific SE（Luxembourg）
Bio-Rad Laboratories, Inc.（US）
Myriad Genetics, Inc.（US）
Fluidigm Corporation（US）
PerkinElmer, Inc.（US）
Twist Bioscience Corporation（US）
Natera, Inc.（US）
Veracyte, Inc.（US）
Personalis, Inc.（US）
10x Genomics, Inc.（US）
Quest Diagnostics（US）

結論と提言

Product Code: SQMIG35H2173

Genomics Market size was valued at USD 37.1 billion in 2023 and is poised to grow from USD 41.66 billion in 2024 to USD 105.39 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The genomics sector is witnessing significant transformation, driven by advancements in the understanding of DNA structure, function, and mapping. As the global incidence of cancer escalates, so does government support, with increased funding fueling innovative genomics projects. This surge has enabled the emergence of personalized medicine, revolutionizing treatment strategies in clinical oncology and rare genetic disorders. Concurrently, academia is delving into the correlations between genetics and cognitive disorders, further expanding genomics applications. The heightened focus on cancer research, coupled with a demand for expedited clinical diagnostics and robust investments from government bodies and biopharmaceutical firms, is propelling the genomics market towards rapid revenue growth. This multifaceted evolution reflects the profound impact genomics has on healthcare and medical sciences.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genomics Market Segments Analysis

Global Genomics Market is segmented by Offering, Product Type, Technology, Service Type, Application, Study Type, End User and region. Based on Offering, the market is segmented into Products and Services. Based on Product Type, the market is segmented into Reagents, Kits, And Consumables, Instruments and Bioinformatics Tools. Based on Technology, the market is segmented into Sequencing, PCR, Gene Editing,Flow Cytometry, Microarrays, In Situ Hybridization and Other Technologies. Based on Service Type, the market is segmented into Genomic Profiling and Sequencing Services, Sample Preparation and Library Preparation Services and Bioinformatics Services. Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics and Other Applications. Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics and Other Study Types. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Clinics, Academic and Research Institutes, Pharmaceutical And Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genomics Market

The Genomics market is experiencing significant growth due to the expanding utilization of Next-Generation Sequencing (NGS) in various applications, particularly in cancer research. This technology encompasses a range of uses, including whole-genome sequencing, the exploration of genomic diversity, metagenomics, epigenetic studies, the identification of non-coding RNAs and protein-binding sites, as well as gene-expression profiling via RNA sequencing. Each of these applications enhances our understanding of genetics and disease, thereby fueling demand in the Genomics market. The increasing reliance on NGS technologies signifies their crucial role in advancing genomic studies and innovations.

Restraints in the Genomics Market

The genomics market is facing potential challenges, particularly regarding the availability of skilled personnel, which is a common constraint in many industries. Additionally, the high costs associated with genomic equipment and the complexities of data storage-stemming from sequenced data between 2023 and 2031-may hinder market growth. While the incorporation of genomic technologies in healthcare has the capacity to improve safety, quality, efficiency, and overall cost-effectiveness, realizing these advantages is heavily contingent upon having access to qualified professionals. Thus, without addressing these limitations, the expansion and effectiveness of the genomics market could be significantly impacted.

Market Trends of the Genomics Market

The genomics market is witnessing a pivotal shift as Illumina phases out its OmniExpress chip in favor of the customized Global Screening Array (GSA) microarray. This transition is compelling companies like Ancestry.com to adapt quickly by either adopting the GSA, integrating Thermo Fisher Scientific products, or investing in next-generation sequencing (NGS) technology. This trend underscores a broader movement within the genomics industry toward enhanced precision, scalability, and cost-effectiveness in genetic analysis. As organizations pivot to maintain competitive advantages, the demand for innovative sequencing solutions is expected to accelerate, driving growth and transformation in the genomics landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Regulatory Analysis
Technology Analysis
Case Studies

Global Genomics Market Size by Offering & CAGR (2025-2032)

Market Overview
Products
Services

Global Genomics Market Size by Product Type & CAGR (2025-2032)

Market Overview
Reagents, Kits, And Consumables
Instruments
Bioinformatics Tools

Global Genomics Market Size by Technology & CAGR (2025-2032)

Market Overview
Sequencing
PCR
Gene Editing
Flow Cytometry
Microarrays
In Situ Hybridization
Other Technologies

Global Genomics Market Size by Service Type & CAGR (2025-2032)

Market Overview
Genomic Profiling and Sequencing Services
Sample Preparation and Library Preparation Services
Bioinformatics Services

Global Genomics Market Size by Application & CAGR (2025-2032)

Market Overview
Drug Discovery and Development
Diagnostics
- Infectious Diseases
- Reproductive Health
- Other Diagnostic Applications
- Agriculture And Animal Research
Other Applications

Global Genomics Market Size by Study Type & CAGR (2025-2032)

Market Overview
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Other Study Types

Global Genomics Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals, Diagnostic Laboratories, and Clinics
Academic and Research Institutes
Pharmaceutical And Biotechnology Companies
Other End Users

Global Genomics Market Size & CAGR (2025-2032)

North America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- US
- Canada
Europe (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies, Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veracyte, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Personalis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ゲノミクスの市場規模、シェア、成長分析：提供別、製品タイプ別、技術別、サービスタイプ別、用途別、研究タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Genomics Market Size, Share, and Growth Analysis, By Offering, By Product Type, By Technology, By Service Type, By Application, By Study Type, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ゲノミクス市場規模：提供別

ゲノミクス市場規模：製品タイプ別

ゲノミクス市場規模：技術別

ゲノミクス市場規模：サービスタイプ別

ゲノミクス市場規模：用途別

ゲノミクス市場規模：研究タイプ別

ゲノミクス市場規模：エンドユーザー別

ゲノミクス市場規模